The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.
"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."
Effective January 1, 2021, the Centers for Medicare & Medicaid (CMS) finalized significant changes to…
House Speaker Nancy Pelosi (D-CA) and Treasury Secretary Steven Mnuchin appeared to be moving closer…
On August 3, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician…
Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA). Read More
CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More
04/01/21: Fellow Exam Application Deadline
Learn more
06/01/21: Research Grant Cycle
Learn more
06/26/21: Membership Application Deadline to be eligible for AAOA Member rate for the 2021 Basic Course
08/01/21:Scientific Abstract Submission Deadline
Learn More
09/01/21: Membership Application Deadline to be voted in at the 2021 Annual Meeting
12/01/21: Research Grant Cycle
Learn more
Our 2021 AAOA Basic Course in Allergy & Immunology will be launched June 1st: Over 11 hrs of pre-learning, on-demand will set you up to gain the full value of our curriculum and engage in the live-stream session.
Live Stream July 8-11 will offer unique learning formats to offer learners the core concepts of allergy diagnosis and management. Join us and test your pre-work efforts for our Immunology & Pharmacotheapy Trivia Slams; Great Debates on Environmental Controls; Allergen Testing Panel “Bake Off,” Late Night with Dr. Levy, AAOA’s Escape Room Expedition, Hands On Testing and Dose Calculation Practica, Office Tours, and more.
Structured for otolaryngologists integrating more allergy assessment and management into their practice, AAOA members providing specialized allergy care who need to remain current with literature-based evidence and practice trends, residents, PA/NPs who work in otolaryngology, and allied health staff who support their physicians in the management of allergic patients. The Basic Course offers unique opportunities to learn the state of the art in allergy patient care. Learn More
IFAR Impact Factor: 2.454
IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More
2021 Basic Course in Allergy & Immunology
On-demand June 1; Live Stream July 8-11 | Virtual
Learn More and Register
USP 797 Online Module
Learn More and Register
2021 AAOA Annual Meeting
Pre-launch Mid-September
Live Stream Starting on Oct 16 | Virtual
Learn More
Have novel research tied to allergy, inflammatory disease in ENT, comprehensive management of allergy and…
By Beth Wang / April 15, 2021 at 11:57 AM The House on Wednesday (April 14) passed…
The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.
Release Date: August 14, 2020; Expiration Date: August 13, 2021 Nasal polyps impact an estimated 13 million Americans. In particular, nasal polyps affect 45% of people with adult-onset asthma and approximately 30% of people with chronic rhinosinusitis, in the latter,…
